<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sudhamalla B</submitter><funding>University of Pittsburgh</funding><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><pagination>10263-10269</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6400064</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>140(32)</volume><pubmed_abstract>Ten-eleven translocation (TET) enzymes employ O&lt;sub>2&lt;/sub>, earth-abundant iron, and 2-ketoglutarate (2KG) to perform iterative C-H oxidation of 5-methylcytosine in DNA to control expression of the mammalian genome. Given that more than 60 such C-H oxygenases are present in humans, determining context-dependent functions of each of these enzymes is a pivotal challenge. In an effort to tackle the problem, we developed analogue-sensitive TET enzymes to perturb the activity of a specific member. We rationally engineered the TET2-2KG interface to develop TET2 variants with an expanded active site that can be specifically inhibited by the N-oxalylglycine (NOG) derivatives carrying a complementary steric "bump". Herein, we describe the identification and engineering of a bulky gatekeeper residu</pubmed_abstract><journal>Journal of the American Chemical Society</journal><pubmed_title>Complementary Steric Engineering at the Protein-Ligand Interface for Analogue-Sensitive TET Oxygenases.</pubmed_title><pmcid>PMC6400064</pmcid><funding_grant_id>R01GM123234</funding_grant_id><funding_grant_id>R01 GM123234</funding_grant_id><pubmed_authors>Kavoosi S</pubmed_authors><pubmed_authors>Snyder V</pubmed_authors><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Islam K</pubmed_authors><pubmed_authors>Sudhamalla B</pubmed_authors><pubmed_authors>Arora S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Complementary Steric Engineering at the Protein-Ligand Interface for Analogue-Sensitive TET Oxygenases.</name><description>Ten-eleven translocation (TET) enzymes employ O&lt;sub>2&lt;/sub>, earth-abundant iron, and 2-ketoglutarate (2KG) to perform iterative C-H oxidation of 5-methylcytosine in DNA to control expression of the mammalian genome. Given that more than 60 such C-H oxygenases are present in humans, determining context-dependent functions of each of these enzymes is a pivotal challenge. In an effort to tackle the problem, we developed analogue-sensitive TET enzymes to perturb the activity of a specific member. We rationally engineered the TET2-2KG interface to develop TET2 variants with an expanded active site that can be specifically inhibited by the N-oxalylglycine (NOG) derivatives carrying a complementary steric "bump". Herein, we describe the identification and engineering of a bulky gatekeeper residu</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Aug</publication><modification>2026-05-05T06:28:00.586Z</modification><creation>2025-05-29T20:01:53.177Z</creation></dates><accession>S-EPMC6400064</accession><cross_references><pubmed>30028600</pubmed><doi>10.1021/jacs.8b05283</doi></cross_references></HashMap>